We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

02 Jun 2026 - 04 Jun 2026
17 Jun 2026 - 19 Jun 2026
05 Oct 2026 - 06 Oct 2026

Genetic Test for Hereditary Colon Cancer

By HospiMedica staff writers
Posted on 10 Oct 2000
A new genetic test for colon cancer detects disease-causing mutations in two genes, MLH1 and MSH2, which are responsible for the majority of cases of hereditary colon cancer. More...
The risk of colon cancer in an individual is increased 40 times by one of these mutations, to about 80%, from just 2% for the general population.

The test, called Colaris, was developed by Myriad Genetics, Inc. (Salt Lake City, UT, USA) and utilizes the same DNA sequencing technology used in Myriad's tests for identifying the risk of breast and ovarian cancer. The company states that the technology provides the most accurate assessment of risk to patients based on their genetic makeup.

People who are at high risk for colon cancer, following a positive Colaris test, can have earlier and more frequent exams and have precancerous polyps removed, said Gregory Critchfield, M.D., president of Myriad Genetics. This course of action has the potential to totally prevent colon cancer.

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
12-Channel ECG
CM1200B
Medical Examination & Procedure Light
Vega 80
New
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Elyra TFL System uses thulium fiber laser technology for efficient stone dusting and reduced stone migration, with an air-cooled design for quieter, more compact operation (photo courtesy of BD

BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures

BD (Becton, Dickinson and Company) has introduced the Elyra Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete its kidney stone care portfolio for urology teams.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.